Janux Therapeutics, Inc.

Historical 13F Holders

Symbol
JANX
CUSIP
47103J105
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 186 65.5 M $1.51 B
2025 Q1 196 66.5 M $1.81 B
2024 Q4 233 64.1 M $3.43 B
2024 Q3 171 45.6 M $2.07 B
2024 Q2 170 46.3 M $1.94 B
2024 Q1 132 43.1 M $1.62 B
2023 Q4 72 33.6 M $361 M
2023 Q3 62 35.1 M $354 M
2023 Q2 57 30.5 M $362 M
2023 Q1 51 30.5 M $370 M
2022 Q4 54 29.2 M $385 M
2022 Q3 51 31.5 M $427 M
2022 Q2 45 28.9 M $353 M
2022 Q1 48 28.4 M $407 M
2021 Q4 47 27.5 M $542 M
2021 Q3 46 26.5 M $571 M
2021 Q2 31 24.7 M $614 M